AU2003252249A1 - Method of judging cancer based on the expression of homeobox gene - Google Patents

Method of judging cancer based on the expression of homeobox gene

Info

Publication number
AU2003252249A1
AU2003252249A1 AU2003252249A AU2003252249A AU2003252249A1 AU 2003252249 A1 AU2003252249 A1 AU 2003252249A1 AU 2003252249 A AU2003252249 A AU 2003252249A AU 2003252249 A AU2003252249 A AU 2003252249A AU 2003252249 A1 AU2003252249 A1 AU 2003252249A1
Authority
AU
Australia
Prior art keywords
expression
cancer based
homeobox gene
judging cancer
judging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003252249A
Inventor
Jun-Ichi Hamada
Tetsuya Moriuchi
Mitsuhiro Tada
Yoko Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hokkaido Technology Licensing Office Co Ltd
Original Assignee
Hokkaido Technology Licensing Office Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hokkaido Technology Licensing Office Co Ltd filed Critical Hokkaido Technology Licensing Office Co Ltd
Publication of AU2003252249A1 publication Critical patent/AU2003252249A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003252249A 2003-07-23 2003-07-23 Method of judging cancer based on the expression of homeobox gene Abandoned AU2003252249A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2003/009340 WO2005010180A1 (en) 2003-07-23 2003-07-23 Method of judging cancer based on the expression of homeobox gene

Publications (1)

Publication Number Publication Date
AU2003252249A1 true AU2003252249A1 (en) 2005-02-14

Family

ID=34090541

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003252249A Abandoned AU2003252249A1 (en) 2003-07-23 2003-07-23 Method of judging cancer based on the expression of homeobox gene

Country Status (3)

Country Link
JP (1) JPWO2005010180A1 (en)
AU (1) AU2003252249A1 (en)
WO (1) WO2005010180A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9556430B2 (en) 2005-05-27 2017-01-31 Dana-Farber Cancer Institute, Inc. Gene methylation and expression
CN107446033B (en) 2006-02-22 2022-04-01 朱正崙 Treatment of developmental related disorders
JP2007267700A (en) * 2006-03-31 2007-10-18 Kochi Univ Method for judging malignant tumor including nephrocyte cancer with methylation of hoxb 13 gene
WO2007143037A2 (en) * 2006-05-31 2007-12-13 Orion Genomics Llc Gene methylation in cancer diagnosis
WO2009144690A1 (en) * 2008-04-14 2009-12-03 Royal College Of Surgeons In Ireland A method of assessing cancer status in a breast cancer patient
WO2012021887A2 (en) 2010-08-13 2012-02-16 Arizona Borad Of Regents, A Body Corporate Acting For And On Behalf Of Arizona State University Biomarkers for the early detection of breast cancer
KR101612356B1 (en) 2014-06-10 2016-04-15 연세대학교 산학협력단 Use of HOXB5 for diagnosis and treatment of breast cancer
CN105988010B (en) * 2015-03-03 2021-01-19 江苏太和吉英医药科技有限公司 Phosphorylated HOXA10 as a method for endometrial receptivity detection
CN106480078A (en) * 2015-08-27 2017-03-08 上海交通大学医学院附属瑞金医院 One group of gastric cancer peritoneum Metastatic Marker and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000007632A1 (en) * 1998-08-04 2000-02-17 Diadexus Llc A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
WO2000016805A1 (en) * 1998-09-23 2000-03-30 Diadexus Llc Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer
EP1285970A3 (en) * 2001-06-26 2004-05-19 National Taiwan University Metastasis-associated genes

Also Published As

Publication number Publication date
WO2005010180A1 (en) 2005-02-03
JPWO2005010180A1 (en) 2006-09-07

Similar Documents

Publication Publication Date Title
AU2003214873A1 (en) Methods of treating conditions associated with an edg receptor
AU2003300368A1 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
AU2003218346A1 (en) Influence of surface geometry on metal properties
AU2003299864A8 (en) Sirna compounds and methods for the downregulation of gene expression
AU2003303735A1 (en) Oligomer silasesquioxanes, method for the production thereof, and use of the same
AU2003252249A1 (en) Method of judging cancer based on the expression of homeobox gene
AU2003223538A1 (en) Methods for the treatment of cancer
AU2003226452A1 (en) Method of defining the differentiation grade of tumor
AU2003264502A1 (en) Novel carbonyl reductase, gene thereof and method of using the same
AU2003218208A1 (en) Methods for diagnosis and prognosis of cancer
AU2003202205A1 (en) Methods for identifying cancer risk
AU2003278211A1 (en) Methods for detection of genetic alterations associated with cancer
AU2003212826A1 (en) Cancer genes
AU2003287300A1 (en) Identification of diet-regulated disease-associated genes
AU2002322417A1 (en) An improved hydrocracking process
AU2003290762A1 (en) Method of forming hydroformed member with opening
AU2003903274A0 (en) Method of assessing cancer risk
AU2003294705A1 (en) NtSM GENE
AU2003245366A1 (en) Methods for improving rna transcription reactions
AU2003241182A1 (en) Stat6 activation gene
AU2003294272A1 (en) Methods for diagnosing the presence or stage of cancer
AU2003302040A1 (en) Novel cancer-associated gene
AU2003277902A1 (en) Acc gene
AU2003278748A1 (en) Chemotherapy method using-rays background of the invention
AU2003242033A1 (en) Method of diagnosing cancer and method of judging cancer risk

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase